Ignite Creation Date:
2025-12-24 @ 12:53 PM
Ignite Modification Date:
2026-01-31 @ 11:24 AM
Study NCT ID:
NCT00350961
Status:
COMPLETED
Last Update Posted:
2008-08-26
First Post:
2006-07-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma
Sponsor:
Rigshospitalet, Denmark
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GEMOXEL cholangiocarcinoma
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |